Minirin Melt 60 Mcg 30 Tablets

Minirin Melt 60 Mcg 30 Tablets

Description:

Minirin Melt 60 mcg is a prescription medicine containing desmopressin acetate, a synthetic analogue of the natural antidiuretic hormone (ADH). It is formulated as sublingual tablets that dissolve under the tongue, providing a convenient, water-free option for patients who require control of excessive urine production. Minirin Melt is primarily used to treat conditions associated with impaired water balance and excessive urination, helping to reduce urine volume, control frequent night-time urination, and improve quality of life under medical supervision.

Indications:

• Central diabetes insipidus: management of excessive urination (polyuria) and excessive thirst (polydipsia) due to deficiency of antidiuretic hormone.
• Nocturia and nocturnal polyuria (in selected patients as directed by a specialist): reduction of night-time urine production and frequency of night-time urination.
• Primary nocturnal enuresis (bedwetting) in children and adults when organic causes have been excluded and under physician supervision (depending on local approved indications).
• Conditions where controlled antidiuretic effect is required as determined by a physician.

Active Ingredients / Key Components:

• Desmopressin acetate – 60 mcg per sublingual tablet.
• Excipients: Full list of inactive ingredients (such as tablet base, sweeteners, and stabilizers) is not available in the provided information. Please refer to the official package leaflet for complete excipient details.

Dosage & Administration / How to Use:

• Minirin Melt 60 mcg is for sublingual use only. Do not swallow whole. Place the tablet under the tongue and allow it to dissolve completely without chewing or drinking water.
• Recommended dose and frequency are individualized by the treating physician based on indication, age, kidney function, and clinical response.
• For central diabetes insipidus: dosing is usually divided 1–3 times daily, titrated to control thirst and urine output while avoiding fluid overload. Follow your doctor’s exact instructions.
• For nocturnal polyuria or nocturnal enuresis (if prescribed for these indications): usually taken in the evening about 1 hour before bedtime, with fluid restriction starting 1 hour before and lasting at least 8 hours after the dose. Exact dose and duration must be determined by the physician.
• Do not drink excessive fluids from 1 hour before taking Minirin Melt until at least 8 hours after each dose to reduce the risk of water retention and low blood sodium (hyponatremia).
• If a dose is missed, take it as soon as you remember unless it is close to the time for the next dose. Do not double the dose to make up for a missed dose. Consult your doctor or pharmacist if unsure.
• Use in children, elderly patients, and patients with comorbidities must be strictly under medical supervision with appropriate monitoring of fluid intake and serum sodium.

Clinical Benefits:

• Provides potent antidiuretic effect by selectively stimulating V2 receptors in the kidney collecting ducts, increasing water reabsorption and reducing urine volume.
• Helps control excessive urination and thirst in central diabetes insipidus, improving hydration balance and daily comfort.
• Reduces night-time urine production and frequency of night-time urination in indicated patients, supporting better sleep quality and reduced sleep disruption.
• Convenient sublingual melt formulation that dissolves under the tongue without the need for water, suitable for patients who have difficulty swallowing or require fluid restriction.

Warnings & Contraindications:

• Use only under the supervision of a physician experienced in managing disorders of water balance. Strictly follow prescribed dose and fluid intake recommendations.
• Contraindicated in patients with known hypersensitivity to desmopressin acetate or any of the excipients.
• Contraindicated in patients with moderate to severe renal impairment (usually creatinine clearance < 50 ml/min) due to increased risk of water retention and hyponatremia.
• Contraindicated in patients with hyponatremia or a history of hyponatremia, or conditions associated with fluid overload (e.g., heart failure, uncontrolled hypertension).
• Use with extreme caution in elderly patients, children, and patients at risk of electrolyte imbalance. Regular monitoring of serum sodium and fluid status is recommended.
• Concomitant use with drugs that increase the risk of water retention or hyponatremia (e.g., certain antidepressants such as SSRIs or tricyclics, carbamazepine, NSAIDs) should be carefully evaluated by the physician.
• Limit fluid intake from 1 hour before taking Minirin Melt until at least 8 hours after each dose to reduce the risk of water intoxication and hyponatremia.
• Consult your doctor before use if pregnant or planning pregnancy. Desmopressin should be used in pregnancy only if clearly needed and under medical supervision.
• If breastfeeding, consult your healthcare provider before use. The physician will weigh potential benefits and risks.
• Patients with conditions such as cystic fibrosis, coronary artery disease, hypertension, or those on diuretics or other medications affecting fluid/electrolyte balance should inform their doctor before starting therapy.
• Do not use Minirin Melt for any indication other than that prescribed by your doctor.
• Consult your doctor before use if you have liver disease, heart disease, kidney disease, uncontrolled hypertension, or a history of low blood sodium.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision.
• Keep out of reach of children.

Side Effects:

• Common side effects may include headache, nausea, abdominal pain, mild nasal or throat discomfort (if previously using intranasal forms), and mild fluid retention.
• Serious side effect: hyponatremia (low blood sodium) due to water retention, which may present with symptoms such as headache, nausea, vomiting, weight gain, confusion, drowsiness, muscle cramps, or in severe cases seizures and loss of consciousness. This is a medical emergency and requires immediate medical attention.
• Other possible side effects can include dizziness, increased blood pressure or changes in blood pressure, and allergic reactions such as rash, itching, or swelling. Stop the medication and seek urgent medical help if signs of severe allergy (difficulty breathing, swelling of face, lips, tongue, or throat) occur.
• If you experience any unusual symptoms, sudden weight gain, persistent headache, or neurological symptoms, stop taking Minirin Melt and contact your doctor immediately.

Storage Instructions:

Store in a cool, dry place away from direct sunlight and moisture. Keep the blister pack tightly closed until use to protect the sublingual tablets from humidity. Do not store above the temperature recommended in the official package leaflet (exact temperature not available in the provided information). Keep out of reach of children.

Specifications:

• Product type: Prescription medicine – antidiuretic hormone analogue.
• Active ingredient strength: desmopressin acetate 60 mcg per sublingual tablet.
• Form: sublingual tablet (melt) – designed to dissolve under the tongue without water.
• Pack size: 30 sublingual tablets per pack.
• Intended users: Adults and children as prescribed by a physician, for indicated conditions such as central diabetes insipidus and nocturnal polyuria/enuresis (depending on local approved indications).

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.